Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutation screening in juvenile polyposis syndrome.

Robert E Pyatt1, Robert Pilarski, Thomas W Prior

  • 1Department of Pathology, Ohio State University, Hamilton Hall 125, 1645 Neil Ave., Columbus, OH 43210, USA.

The Journal of Molecular Diagnostics : JMD
|January 27, 2006
PubMed
Summary

Juvenile polyposis syndrome (JPS) genetic testing identified mutations in 30% of patients, primarily in MADH4 and BMPR1A genes. This aids in diagnosing this cancer predisposition syndrome and enables presymptomatic genetic testing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a Digital Tool That Uses National Testing Guidelines to Identify Individuals at Risk for Hereditary Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Clinical <i>SMN1</i> and <i>SMN2</i> Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing.

Human mutation·2025
Same author

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak.

Annals of internal medicine·2022
Same author

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2022
Same author

Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer.

NPJ genomic medicine·2022
Same author

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.

Leukemia·2022

Area of Science:

  • Genetics
  • Oncology
  • Gastroenterology

Background:

  • Juvenile polyposis syndrome (JPS) is an autosomal dominant disorder.
  • It is characterized by hamartomatous polyps and increased cancer risk.
  • Diagnosis is challenging due to overlapping symptoms with other polyposis syndromes.

Observation:

  • This study analyzed 70 unrelated individuals for JPS genetic mutations.
  • Sequence analysis of MADH4 and BMPR1A genes was performed.
  • Congenital anomalies and cancer status were also assessed.

Findings:

  • Germline mutations were found in 30% of JPS cases (11.4% BMPR1A, 18.6% MADH4).
  • Most identified mutations were novel, including the first MADH4 splice site alteration.
  • No cancer was detected in mutation-positive individuals; only one reported congenital anomaly (pulmonary valve stenosis).

Related Experiment Videos

Implications:

  • Direct sequence analysis of coding regions and exon-intron boundaries is effective for JPS mutation screening.
  • Identifying mutations aids in presymptomatic diagnosis and genetic counseling.
  • Understanding mutation types informs diagnostic strategies for JPS.